Newsfeed

Govt expresses concern over recent spike in COVID-19 cases in Maharashtra, Punjab

Government has expressed concern over the recent spike in COVID-19 cases in Maharashtra and Punjab. Addressing media in New Delhi yesterday, Union Health Secretary Rajesh Bhushan said Maharashtra and Punjab are of grave concern which have shown recent surge in new cases. Maharashtra reported highest 28,699 cases in last 24 hours followed by Punjab with 2,254 cases. The Health Secretary said, India’s total Active Caseload has reached 3 lakh 68 thousand 457 today which is 3.14 per cent of total cases and top ten districts where maximum active cases are concentrated are Pune, Nagpur, Mumbai, Thane, Nashik, Aurangabad, Nanded, Jalgaon, Akola and Bengaluru Urban.

The Health Ministry added that the revised time interval between two doses of COVID Vaccine is applicable only to Covishield and not to Covaxin vaccine. These two vaccines are being utilised in the ongoing vaccination drive. Health Secretary Rajesh Bhushan said, time interval between two doses of Covishield vaccine has been increased to 4 to 8 weeks after the first dose instead of earlier practiced interval of 4 to 6 weeks. He said, protection is enhanced if the second dose of Covishield is administered between 6 to 8 weeks but not later than stipulated period of 8 weeks. The Health Secretary added that in case of Covaxin, the time interval between the two doses continues to be 4 to 6 weeks.

He also informed that the government has allowed the citizens aged more than 45 years for COVID vaccination from 1st of next month and the conditions of comorbidities have been removed. He also informed that the registration for vaccination will begin from 1st of next month and the decision in this regard was taken as 88 per cent of all covid deaths are taking place in the country in the age group of 45 years and above. On Genome Sequencing, Director of National Centre for Disease Control Dr Sujeet Kumar Singh said, the Genome Sequencing by the Indian SARS-CoV-2 Consortium on Genomics, INSACOG has sequenced 10787 SARS CoV-2 genome from COVID-19 positive international travellers as well as from the country. He said, so far 771 variant have been detected  in 18 States out of which  736 are UK Variants, 34 are South African Variant and  one sample was found positive for viruses of the Brazilian lineage. He said, so far no linkage has been seen with surge in Covid-19 cases due to foreign travellers.

NITI Aayog, Member Dr V K Paul said, the government has adequate supplies of vaccines to deliver on the vaccination programme and there is no shortage of it. He said, supplies of vaccines are assured, efficient and satisfactory at the district and State level as well as the place where vaccination is being done. Dr Paul said that Adverse Events following Immunization (AEFI) Committee has concluded that there is no problem of thrombosis event due to Covishield vaccine and it is safe.

 

Support Ethical Journalism. Support The Dispatch

The Dispatch is a sincere effort in ethical journalism. Truth, Accuracy, Independence, Fairness, Impartiality, Humanity and Accountability are key elements of our editorial policy. But we are still not able to generate great stories, because we don’t have adequate resources. As more and more media falls into corporate and political control, informed citizens across the world are funding independent journalism initiatives. Here is your chance to support your local media startup and help independent journalism survive. Click the link below to make a payment of your choice and be a stakeholder in public spirited journalism


 

The Dispatch is present across a number of social media platforms. Subscribe to our YouTube channel for exciting videos; join us on Facebook, Intagram and Twitter for quick updates and discussions. We are also available on the Telegram. Follow us on Pinterest for thousands of pictures and graphics. We care to respond to text messages on WhatsApp at 8082480136 [No calls accepted]. To contribute an article or pitch a story idea, write to us at [email protected] |Click to know more about The Dispatch, our standards and policies